Zymeworks Inc. (ZYME) Earnings History
Annual and quarterly earnings data from 2014 to 2025
Loading earnings history...
ZYME EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ZYME Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 89.8% | -87.3% | -76.6% |
| 2024 | 100.0% | -179.7% | -160.8% |
| 2023 | -88.1% | -181.6% | -156.1% |
| 2022 | 100.0% | 31.6% | 30.1% |
| 2021 | 100.0% | -808.2% | -794.0% |
Download Data
Export ZYME earnings history in CSV or JSON format
Free sign-in required to download data
Zymeworks Inc. (ZYME) Earnings Overview
As of May 8, 2026, Zymeworks Inc. (ZYME) reported trailing twelve-month net income of -$44.22B, reflecting +33.3% year-over-year growth. The company earned $-592.01 per diluted share over the past four quarters, with a net profit margin of -76.6%.
Looking at the long-term picture, ZYME's historical earnings data spans multiple years. The company achieved its highest annual net income of $124M in fiscal 2022.
Zymeworks Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMVT (-$464M net income), RCUS (-$369M net income, -142.9% margin), MRUS (-$335M net income, -595.9% margin), ZYME has comparable earnings metrics. Compare ZYME vs IMVT →
ZYME Earnings vs Peers
Earnings metrics vs comparable public companies
ZYME Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$81M | +33.9% | -$93M | $-1.08 | -76.6% | -87.3% |
| 2024 | -$123M | -3.4% | -$137M | $-1.62 | -160.8% | -179.7% |
| 2023 | -$119M | -195.4% | -$138M | $-1.72 | -156.1% | -181.6% |
| 2022 | $124M | +158.7% | $131M | $1.90 | 30.1% | 31.6% |
| 2021 | -$212M | -17.3% | -$216M | $-4.61 | -794.0% | -808.2% |
| 2020 | -$181M | -24.1% | -$187M | $-3.58 | -463.5% | -481.3% |
| 2019 | -$145M | -297.8% | -$151M | $-3.83 | -492.3% | -512.1% |
| 2018 | -$37M | -251.3% | -$33M | $-1.26 | -68.9% | -62.5% |
| 2017 | -$10M | +69.2% | -$9M | $-0.49 | -20.1% | -17.4% |
| 2016 | -$34M | -76.4% | -$38M | $-1.72 | -307.1% | -343.9% |
See ZYME's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZYME Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZYME vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZYME — Frequently Asked Questions
Quick answers to the most common questions about buying ZYME stock.
Is ZYME growing earnings?
ZYME EPS is $-592.01, with earnings growth accelerating to +33.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-44.2B.
What are ZYME's profit margins?
Zymeworks Inc. net margin is -76.6%, with operating margin at -87.3%. Below-average margins reflect competitive or cost pressures.
How consistent are ZYME's earnings?
ZYME earnings data spans 2014-2025. The accelerating earnings trend is +33.3% YoY. Historical data enables comparison across business cycles.